Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 614.00
Bid: 614.00
Ask: 620.00
Change: 2.00 (0.33%)
Spread: 6.00 (0.977%)
Open: 628.00
High: 628.00
Low: 614.00
Prev. Close: 612.00
PRV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM/Interim Management Stmt

7 Apr 2009 07:00

RNS Number : 2397Q
Porvair PLC
07 April 2009
 



For immediate release 7 April 2009

Porvair plc ("Porvair" or "The Group")

AGM Statement and Interim Management Statement

Porvair, the specialist filtration and environmental technology group will today make the following interim management statement at its Annual General Meeting:

In the four months ended 31 March 2009 the Group's UK and European operations have continued to trade well.  Over the same period trading in the US has deteriorated. Cash generation across the Group has been in line with expectations

The Microfiltration division, based in the UK and Europe, is trading well with the order book supported by account wins, new project work and currency benefits Energy filtration is having a very good year with gasification and nuclear remediation demand strong. Some Aviation schedules have weakened, notably in regional and corporate jets, but new projects have made up for any shortfall in overall demand.  New products have been launched in bioscience filtration.  Current trading at Seal Analytical is encouraging with acquisition integration actions almost complete.

Trading in the US has been more challenging. Sales in the Metals Filtration division fell around 15early in the year, and a further 20% during the course of February and early March. In response employee numbers have been cut by 40% and salaries of remaining staff temporarily reduced.  These actions will give rise to a one-off charge of circa £600,000. Annualised costs in Metals Filtration will be approximately £1.5m lower as a result.

To reflect current trading, the Board has amended its expectations for the year. Including one-off costs, mostly US redundancies, the Group is likely to incur a small operating loss in the first half of the year. Cash generation should remain in line with management plans. Expectations of a stronger performance in the second half are underpinned by orders in the UK due for delivery later in the year and the much lower US cost base.

The Group retains the support of its bankers, Barclays, who are reviewing the amended expectations for the year. The Board expects to be able to agree revised banking arrangements in due course.

In spite of difficult trading conditions in the US, the Board has noticed some more promising signs in recent weeks.  Cash generation has been very good in the first four months of the year and raw material initiatives will drive down inventories further in the months ahead. The US sales run rate, whilst 35% down on the same period in 2008, appears to have stabilisedMuch work has been done in prior years to position new products in key market segments. The Board is pleased to see this activity now accelerating and margins picking up as a result. 30% of our aluminium customers have converted to the new proprietary filter launched in 2008. This product is being offered at a price premium based on superior technical performance. The new iron foundry filter is in advanced customer qualifications and is performing well. First deliveries of our energy storage component have been made These products, along with a significantly lower cost base in Metals Filtration, should enable a swift recovery as demand picks up. 

The Group will give a further update on trading at the end of its half year in early June 2009. A full interim statement will be made on 22 June 2009.

For further information, please contact:

Porvair plc

01553 765 500

Ben Stocks, Chief Executive

Chris Tyler, Group Finance Director

 

Buchanan Communications

0207 466 5000

Charles Ryland / Catherine Breen

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUUURWCUPBGBQ
Date   Source Headline
23rd Apr 20241:38 pmRNSDirector/PDMR Shareholding
16th Apr 20242:56 pmRNSAGM Results Announcement
16th Apr 20247:00 amRNSAGM Trading Update & Board Update
3rd Apr 20247:00 amRNSDirector resignation
12th Mar 20247:00 amRNSDirector declaration
29th Feb 20247:00 amRNSTotal Voting Rights
8th Feb 20244:41 pmRNSHolding(s) in Company
8th Feb 20244:27 pmRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSResults for the year ended 30 November 2023
1st Feb 20247:00 amRNSBlock listing Interim Review
19th Dec 202310:25 amRNSHolding(s) in Company
5th Dec 20237:00 amRNSTrading Update & Acquisition
4th Dec 202312:00 pmRNSHolding(s) in Company
25th Sep 202310:00 amRNSDirector/PDMR Shareholding
12th Sep 20237:00 amRNSNine Month Trading Update
21st Aug 20237:00 amRNSDirector/PDMR Shareholding
17th Jul 20237:00 amRNSAcquisition completion
7th Jul 20234:00 pmRNSBlock Listing Application
3rd Jul 20237:00 amRNSInterim Results
26th Jun 20237:00 amRNSBoard Change
21st Jun 20234:22 pmRNSHolding(s) in Company
21st Jun 20237:00 amRNSDirector/PDMR Shareholding
15th Jun 20237:00 amRNSBlock listing Interim Review
4th May 20237:00 amRNSAcquisitions
18th Apr 202312:51 pmRNSAGM resolutions
18th Apr 20237:00 amRNSAGM Trading Update
31st Mar 20234:00 pmRNSTotal Voting Rights
22nd Mar 20233:03 pmRNSGrant of options
1st Mar 20239:30 amRNSTotal Voting Rights
2nd Feb 20235:42 pmRNSGrant of LTSP awards
30th Jan 20237:00 amRNSResults for the year ended 30 November 2022
17th Jan 20234:40 pmRNSSecond Price Monitoring Extn
17th Jan 20234:35 pmRNSPrice Monitoring Extension
9th Dec 20227:00 amRNSTrading Update, Notice of Results and Board Change
1st Dec 20224:00 pmRNSDirector/PDMR Shareholding
1st Dec 202210:00 amRNSTotal Voting Rights
29th Nov 20224:35 pmRNSPrice Monitoring Extension
1st Nov 20224:00 pmRNSBlock listing Interim Review
1st Nov 20227:00 amRNSTotal Voting Rights
27th Oct 20229:30 amRNSDirector declaration and resignation
12th Oct 20224:26 pmRNSDirector/PDMR Shareholding
5th Oct 20225:30 pmRNSHolding(s) in Company
5th Oct 20225:30 pmRNSHolding(s) in Company
4th Oct 20227:00 amRNSTrading Update-Ahead of Expectations
22nd Sep 20224:41 pmRNSSecond Price Monitoring Extn
22nd Sep 20224:36 pmRNSPrice Monitoring Extension
20th Sep 20224:41 pmRNSSecond Price Monitoring Extn
20th Sep 20224:36 pmRNSPrice Monitoring Extension
13th Sep 20227:00 amRNSNine Month Trading Update
9th Sep 20224:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.